metoprolol succinate + metoprolol

Metoprolol succinate + metoprolol refers to a combination or sequential use of two salt forms of the cardioselective beta-1 adrenergic receptor blocker metoprolol. Metoprolol succinate is an extended-release formulation (marketed as Toprol-XL) designed for once-daily administration, primarily indicated for hypertension, angina pectoris, and stable heart failure. Metoprolol (typically administered as the tartrate salt, marketed as Lopressor) is an immediate-release formulation used for hypertension, angina, and the acute management of myocardial infarction. Metoprolol works by competitively antagonizing beta-1 adrenergic receptors in cardiac tissue, which reduces heart rate, cardiac contractility, and blood pressure, thereby decreasing myocardial oxygen demand and providing cardioprotective benefits. This combination is often discussed in clinical contexts regarding the transition from acute immediate-release or intravenous therapy to long-term maintenance with extended-release formulations.

Brand names

Toprol-XLLopressor

Other names

metoprolol succinate and metoprolol tartratemetoprolol succinate/metoprolol tartrate